BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 9193863)

  • 1. Antimicrobial resistance: implications for managing respiratory failure.
    Chenoweth C; Lynch JP
    Curr Opin Pulm Med; 1997 Mar; 3(2):159-69. PubMed ID: 9193863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antimicrobial activity of tigecycline tested against organisms causing community-acquired respiratory tract infection and nosocomial pneumonia.
    Fritsche TR; Sader HS; Stilwell MG; Dowzicky MJ; Jones RN
    Diagn Microbiol Infect Dis; 2005 Jul; 52(3):187-93. PubMed ID: 16105563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emerging resistance problems among respiratory tract pathogens.
    Lister PD
    Am J Manag Care; 2000 May; 6(8 Suppl):S409-18. PubMed ID: 10977480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Development of beta-lactam antibiotic resistance in gram-negative bacteria and the impact of resistance on therapy].
    Bedenić B
    Lijec Vjesn; 1999; 121(7-8):249-57. PubMed ID: 10573961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Continuous surveillance of antimicrobial resistance among nosocomial gram-negative bacilli from intensive care units in China].
    Chen MJ; Wang H;
    Zhonghua Yi Xue Za Zhi; 2003 Mar; 83(5):375-81. PubMed ID: 12820912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibiotic use in neonatal sepsis.
    Yurdakök M
    Turk J Pediatr; 1998; 40(1):17-33. PubMed ID: 9722468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Distribution and drug-resistance of 3 500 gram-negative bacteria in Guangzhou].
    Xiao QZ; Su DH; Jiang JH; Zhong NS
    Di Yi Jun Yi Da Xue Xue Bao; 2005 Feb; 25(2):132-8. PubMed ID: 15698988
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Strategies for decreasing multidrug antibiotic resistance: role of ototopical agents for treatment of middle ear infections.
    Klein JO
    Am J Manag Care; 2002 Oct; 8(14 Suppl):S345-52. PubMed ID: 12408220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antimicrobial resistance of Gram-negative bacilli isolates from inpatients and outpatients at Yaounde Central Hospital, Cameroon.
    Piéboji JG; Koulla-Shiro S; Ngassam P; Adiogo D; Njine T; Ndumbe P
    Int J Infect Dis; 2004 May; 8(3):147-54. PubMed ID: 15109589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bacteremia in children at a regional hospital in Trinidad.
    Orrett FA; Changoor E
    Int J Infect Dis; 2007 Mar; 11(2):145-51. PubMed ID: 16787754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Problems and dilemmas of antimicrobial resistance.
    Murray BE
    Pharmacotherapy; 1992; 12(6 Pt 2):86S-93S. PubMed ID: 1480504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Streptococcus pneumoniae: does antimicrobial resistance matter?
    Lynch JP; Zhanel GG
    Semin Respir Crit Care Med; 2009 Apr; 30(2):210-38. PubMed ID: 19296420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro activity of ceftaroline (PPI-0903M, T-91825) against bacteria with defined resistance mechanisms and phenotypes.
    Mushtaq S; Warner M; Ge Y; Kaniga K; Livermore DM
    J Antimicrob Chemother; 2007 Aug; 60(2):300-11. PubMed ID: 17548456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antimicrobial activity of a novel peptide deformylase inhibitor, LBM415, tested against respiratory tract and cutaneous infection pathogens: a global surveillance report (2003-2004).
    Watters AA; Jones RN; Leeds JA; Denys G; Sader HS; Fritsche TR
    J Antimicrob Chemother; 2006 May; 57(5):914-23. PubMed ID: 16549511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the in vitro activity of 9 antimicrobials against bacterial strains isolated from patients in intensive care units in brazil: MYSTIC Antimicrobial Surveillance Program.
    Mendes C; Hsiung A; Kiffer C; Oplustil C; Sinto S; Mimica I; Zoccoli C;
    Braz J Infect Dis; 2000 Oct; 4(5):236-44. PubMed ID: 11063555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integration of molecular characterization of microorganisms in a global antimicrobial resistance surveillance program.
    Pfaller MA; Acar J; Jones RN; Verhoef J; Turnidge J; Sader HS
    Clin Infect Dis; 2001 May; 32 Suppl 2():S156-67. PubMed ID: 11320455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of the antimicrobial resistance patterns of gram-negative bacilli isolated from community-private and university-affiliated hospitals from Puerto Rico.
    Vázquez GJ; Robledo IE; Arroyo A; Nadal E; Rodríguez R; Bermúdez M; Colón M
    P R Health Sci J; 2003 Sep; 22(3):265-71. PubMed ID: 14619453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current challenges in antibiotic resistance.
    Hand WL
    Adolesc Med; 2000 Jun; 11(2):427-38. PubMed ID: 10916132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contemporary antimicrobial activity of triple antibiotic ointment: a multiphased study of recent clinical isolates in the United States and Australia.
    Jones RN; Li Q; Kohut B; Biedenbach DJ; Bell J; Turnidge JD
    Diagn Microbiol Infect Dis; 2006 Jan; 54(1):63-71. PubMed ID: 16368476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resistance patterns among selective Gram-negative bacilli from an intensive care unit in Trinidad, West Indies.
    Orrett FA
    Saudi Med J; 2004 Apr; 25(4):478-83. PubMed ID: 15083220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.